Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$505M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$443M |
| 3 |
Alibaba
BABA
|
+$370M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$284M |
| 5 |
Procter & Gamble
PG
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$40M |
| 2 |
Home Depot
HD
|
+$38.9M |
| 3 |
JD.com
JD
|
+$35.3M |
| 4 |
SPDR Gold Trust
GLD
|
+$31.6M |
| 5 |
Tesla
TSLA
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 25.83% |
| 2 | Healthcare | 17.87% |
| 3 | Consumer Discretionary | 13.79% |
| 4 | Technology | 4.61% |
| 5 | Financials | 4.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Moody's
MCO
$82.7B
| $353K | ﹤0.01% |
+1,045
| New | +$351K |
|
927
Sarepta Therapeutics
SRPT
$1.77B
| $342K | ﹤0.01% |
+4,374
| New | +$335K |
|
928
Brunswick
BC
$5.28B
| $338K | ﹤0.01% |
4,184
+729
| +21% | +$67.2K |
|
|
XYZ
929
Block Inc
XYZ
$47.5B
| $333K | ﹤0.01% |
+2,455
| New | +$297K |
|
930
Silicon Laboratories
SLAB
$7.23B
| $327K | ﹤0.01% |
+2,178
| New | +$348K |
|
931
Nutanix
NTNX
$16.9B
| $316K | ﹤0.01% |
+11,791
| New | +$316K |
|
|
CGC
932
Canopy Growth
CGC
$410M
| $314K | ﹤0.01% |
4,137
+986
| +31% | +$75.2K |
|
|
SPR
933
DELISTED
Spirit AeroSystems
SPR
| $314K | ﹤0.01% |
+6,415
| New | +$300K |
|
934
NCR Voyix
VYX
$1.14B
| $313K | ﹤0.01% |
+12,685
| New | +$312K |
|
|
GAP
935
The Gap Inc
GAP
$7.37B
| $307K | ﹤0.01% |
+21,833
| New | +$348K |
|
|
JOBS
936
DELISTED
51job Inc
JOBS
| $302K | ﹤0.01% |
5,155
| – | – |
|
937
Ecolab
ECL
$79.9B
| $300K | ﹤0.01% |
+1,698
| New | +$319K |
|
938
Novavax
NVAX
$1.31B
| $296K | ﹤0.01% |
4,021
+1,581
| +65% | +$141K |
|
939
Teradata
TDC
$2.55B
| $294K | ﹤0.01% |
+5,963
| New | +$273K |
|
940
RB Global
RBA
$17.5B
| $292K | ﹤0.01% |
+4,937
| New | +$290K |
|
941
Ryman Hospitality Properties
RHP
$7.63B
| $289K | ﹤0.01% |
+3,115
| New | +$278K |
|
|
NGD
942
DELISTED
New Gold Inc
NGD
| $281K | ﹤0.01% |
154,471
+90,908
| +143% | +$156K |
|
943
Nike
NKE
$61.9B
| $278K | ﹤0.01% |
+2,068
| New | +$291K |
|
944
Ionis Pharmaceuticals
IONS
$9.4B
| $267K | ﹤0.01% |
+7,201
| New | +$236K |
|
945
Wendy's
WEN
$1.46B
| $266K | ﹤0.01% |
+12,110
| New | +$273K |
|
|
WWE
946
DELISTED
World Wrestling Entertainment
WWE
| $252K | ﹤0.01% |
+4,041
| New | +$223K |
|
947
NovaGold Resources
NG
$3.33B
| $251K | ﹤0.01% |
32,541
+19,725
| +154% | +$139K |
|
948
Sensient Technologies
SXT
$5.53B
| $251K | ﹤0.01% |
+2,987
| New | +$252K |
|
949
Universal Corp
UVV
$1.27B
| $246K | ﹤0.01% |
+4,228
| New | +$233K |
|
950
Twilio
TWLO
$36.6B
| $241K | ﹤0.01% |
+1,464
| New | +$267K |
|
Similar funds
Ray Dalio's Q1 2022 Portfolio in Review
As of Q1 2022, Ray Dalio held 991 positions worth $24.8B, up 44% from $17.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ray Dalio deployed $8.89B of net new capital in Q1 2022, opening 260 new positions and adding to 547 existing holdings. Its largest new stake was Medtronic: 1,880,088 shares worth $209M.
By sector, the portfolio is most concentrated in Consumer Staples at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lowe's Companies, an estimated $40M trimmed.
- Ray Dalio's largest Q1 2022 buy was Medtronic: 1,880,088 shares worth $209M.
- Ray Dalio added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $505M increase.
- Ray Dalio's biggest Q1 2022 reduction was Lowe's Companies, cutting an estimated $40M.
- Ray Dalio fully exited Tesla in Q1 2022, selling an estimated $26.9M.
- Ray Dalio's ten largest holdings make up 34% of its $24.8B portfolio in Q1 2022.
- Ray Dalio opened 260 new positions and closed 23 in Q1 2022.
- Ray Dalio's portfolio value rose 44% quarter-over-quarter to $24.8B.
Based on Bridgewater Associates's 13F filing for Q1 2022, filed 13 May 2022.